Allergan Finds White Knight In $66B Actavis Takeover

Allergan Inc. said Monday it would sell itself to rival drugmaker Actavis PLC for roughly $66 billion in a deal designed to thwart the long-running $55 billion hostile buyout campaign mounted by Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.